- Home
- KLTO vs NLSP Comparison
KLTO vs NLSP Comparison
Compare KLTO & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTO
- NLSP
- Stock Information
- Founded
- KLTO 2019
- NLSP 2015
- Country
- KLTO United States
- NLSP Switzerland
- Employees
- KLTO N/A
- NLSP N/A
- Industry
- KLTO
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- KLTO
- NLSP Health Care
- Exchange
- KLTO NYSE
- NLSP Nasdaq
- Market Cap
- KLTO 4.8M
- NLSP 5.8M
- IPO Year
- KLTO N/A
- NLSP 2021
- Fundamental
- Price
- KLTO $0.22
- NLSP $1.62
- Analyst Decision
- KLTO
- NLSP
- Analyst Count
- KLTO 0
- NLSP 0
- Target Price
- KLTO N/A
- NLSP N/A
- AVG Volume (30 Days)
- KLTO 31.8M
- NLSP 26.4K
- Earning Date
- KLTO 05-15-2025
- NLSP 05-27-2025
- Dividend Yield
- KLTO N/A
- NLSP N/A
- EPS Growth
- KLTO N/A
- NLSP N/A
- EPS
- KLTO N/A
- NLSP N/A
- Revenue
- KLTO N/A
- NLSP N/A
- Revenue This Year
- KLTO N/A
- NLSP N/A
- Revenue Next Year
- KLTO N/A
- NLSP N/A
- P/E Ratio
- KLTO N/A
- NLSP N/A
- Revenue Growth
- KLTO N/A
- NLSP N/A
- 52 Week Low
- KLTO $0.11
- NLSP $1.30
- 52 Week High
- KLTO $13.10
- NLSP $18.40
- Technical
- Relative Strength Index (RSI)
- KLTO N/A
- NLSP 53.77
- Support Level
- KLTO N/A
- NLSP $1.58
- Resistance Level
- KLTO N/A
- NLSP $1.75
- Average True Range (ATR)
- KLTO 0.00
- NLSP 0.10
- MACD
- KLTO 0.00
- NLSP 0.01
- Stochastic Oscillator
- KLTO 0.00
- NLSP 55.73
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.